BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22825236)

  • 1. Improving hepatitis B vaccination rates in the hemodialysis population.
    Richards KR; Hayney MS
    J Am Pharm Assoc (2003); 2012; 52(4):542-4. PubMed ID: 22825236
    [No Abstract]   [Full Text] [Related]  

  • 2. Some considerations about HBV vaccination among HIV patients from Latin America and the Caribbean.
    Jose-Abrego A
    Ann Hepatol; 2019; 18(5):656-657. PubMed ID: 31300217
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical experience with a new recombinant hepatitis-B vaccine in previous non-responders with chronic renal insufficiency.
    Haubitz M; Ehlerding G; Beigel A; Heuer U; Hemmerling AE; Thoma HA
    Clin Nephrol; 1996 Mar; 45(3):180-2. PubMed ID: 8706359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dialysis: Intradermal HBV vaccination is preferable in non-responders.
    Levin A
    Nat Rev Nephrol; 2009 Nov; 5(11):616-7. PubMed ID: 19855423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaccination against hepatitis B virus: current data].
    Zoulim F
    Med Trop (Mars); 1999; 59(4 Pt 2):503-7. PubMed ID: 10901855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.
    Sun HY; Ko WC; Tsai JJ; Lee HC; Liu CE; Wong WW; Su SC; Ho MW; Cheng SH; Yang CH; Lin YH; Miao WJ; Sheng WH; Hung CC
    Am J Gastroenterol; 2009 Apr; 104(4):877-84. PubMed ID: 19259078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AM3 (Inmunoferón) as an adjuvant to hepatitis B vaccination in hemodialysis patients.
    Pérez-García R; Pérez-García A; Verbeelen D; Bernstein ED; Villarrubia VG; Alvarez-Mon M
    Kidney Int; 2002 May; 61(5):1845-52. PubMed ID: 11967036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus vaccine failure resulting in chronic hepatitis B infection.
    O'Halloran JA; De Gascun CF; Dunford L; Carr MJ; Connell J; Howard R; Hall WW; Lambert JS
    J Clin Virol; 2011 Oct; 52(2):151-4. PubMed ID: 21802353
    [No Abstract]   [Full Text] [Related]  

  • 9. Higher rates of chronic hepatitis B infection and low vaccination-induced protection rates among parturients escaping HBsAg prenatal testing in Greece: a 2-year prospective study.
    Karatapanis S; Skorda L; Marinopoulos S; Papastergiou V; Drogosi M; Lisgos P; Antsaklis A
    Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):878-83. PubMed ID: 22588307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched.
    Chien YC; Jan CF; Kuo HS; Chen CJ
    Epidemiol Rev; 2006; 28():126-35. PubMed ID: 16782778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eliminating the threat of chronic hepatitis B in the Asian and Pacific Islander community: a call to action.
    Chao SD; Chang ET; So SK
    Asian Pac J Cancer Prev; 2009; 10(3):507-12. PubMed ID: 19640200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intradermal hepatitis B vaccination in nonresponsive hemodialysis patients.
    Mettang T; Weber J; Schenk U; Machleidt C; Kuhlmann U
    Ren Fail; 1993; 15(5):655-6. PubMed ID: 8290715
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis B vaccination in chronic kidney disease patients: a call for novel vaccines.
    Grzegorzewska AE
    Expert Rev Vaccines; 2014 Nov; 13(11):1317-26. PubMed ID: 25148051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in containing the burden of hepatitis B infection in dialysis and transplant patients in India.
    Potsangbam G; Yadav A; Chandel N; Rathi M; Sharma A; Kohli HS; Gupta KL; Minz M; Sakhuja V; Jha V
    Nephrology (Carlton); 2011 May; 16(4):383-8. PubMed ID: 21114569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The status of immunity against the hepatitis B virus among vaccinated hemodialysis patients: a single center report from Iran.
    Khamene ZR; Sepehrvand N
    Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):547-50. PubMed ID: 17951941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B.
    Lo CM; Liu CL; Chan SC; Lau GK; Fan ST
    J Hepatol; 2005 Aug; 43(2):283-7. PubMed ID: 15964658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients.
    Chanchairujira T; Chantaphakul N; Thanwandee T; Ong-Ajyooth L
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S33-40. PubMed ID: 17044452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cases of ineffective anti-hepatitis B vaccination--own observations].
    Kepa L; Oczko-Grzesik B; Sobala-Szczygieł B; Stolarz W; Wilczek K; Mossor K; Warakomska I; Dziambor AP
    Przegl Epidemiol; 2003; 57(3):491-7. PubMed ID: 14682168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients.
    Charest AF; McDougall J; Goldstein MB
    Am J Kidney Dis; 2000 Nov; 36(5):976-82. PubMed ID: 11054354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the way towards the eradication of chronic hepatitis B.
    Ren H
    J Viral Hepat; 2019 Jul; 26 Suppl 1():3-4. PubMed ID: 31380587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.